Вы и ваши гормоны. Наука о женском здоровье и гормональной контрацепции

165. McCurley, J. L., Mills, P. J., Roesch, S. C. et al. (2015). Chronic stress, inflammation, and glucose regulation in U.S. Hispanics from the HCHS/SOL Sociocultural Ancillary Study. Psychophysiology, 52(8), 1071–1079. http://doi.org/­10.1111/­psyp.­12430.

166. Aschbacher, K., Kornfeld, S., Picard, M. et al. (2014). Chronic stress increases vulnerability to diet-related abdominal fat, oxidative stress, and metabolic risk, Psychoneuroendocrinology, 46, 14–22. doi:10.1016/­j.psyneuen.­2014.­04.­003.

167. Castelli, W. P. (1986). The triglyceride issue: A view from Framingham. American Heart Journal, 112(2), 432–437.

168. Nielsen, S. E., Ahmed, I., & Cahill, L. (2014). Postlearning stress differentially affects memory for emotional gist and detail in naturally cycling women and women on hormonal contraceptives. Behavioral Neuroscience, 128(4), 482–493. doi:10.1037/­a003­6687.

169. Roney, J. R. (in preparation). Cortisol increases in response to sexual attraction.

170. Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011). A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(3), 676–692. doi:10.1016/­j.pnpbp.­2010.­05.­004; Zunszain, P. A., Anacker, C., Cattaneo, A. et al. (2011). Glucocorticoids, cytokines and brain abnormalities in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(3), 722–729. doi:10.1016/­j.pnpbp.­2010.­04.­011.

171. Tsigos, C., & Chrousos, G. P. (2002). Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. Journal of Psychosomatic Research, 53(4), 865–871. doi:10.1016/­S0022-3999­(02)­00429-4; Fries, E., Hesse, J., Hellhammer, J., & Hellhammer, D. H. (2005). A new view on hypocortisolism. Psychoneuroendocrinology, 30(10), 1010–1016. doi:10.1016/­j.psyneuen.­2005.­04.­006.

172. Hannibal, K. E., & Bishop, M. D. (2014). Chronic stress, cortisol dysfunction, and pain: A psychoneuroendocrine rationale for stress management in pain rehabilitation. Physical Therapy, 94(12), 1816–1825. doi:10.2522/­ptj.­2013­05­97.

173. Tsigos, C., & Chrousos, G. P. (2002). Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. Journal of Psychosomatic Research, 53(4), 865–871. doi:10.1016/­S0022-3999­(02)­00429-4; Fries, E., Hesse, J., Hellhammer, J., & Hellhammer, D. H. (2005). A new view on hypocortisolism. Psychoneuroendocrinology, 30(10), 1010–1016. doi:10.1016/­j.psyneuen.­2005.­04.­006.

174. Sørensen, C. J., Pedersen, O. B., Petersen, M. S. et al. (2014). Combined oral contraception and obesity are strong predictors of low-grade inflammation in healthy individuals: Results from the Danish Blood Donor Study (DBDS). PLOS One, 9(2). doi:10.1371/­journal.­pone.­0088196.

175. Williams, W. V. (2017). Hormonal contraception and the development of autoimmunity: A review of the literature. Linacre Quarterly, 84(3), 275–295. doi:10.1080/­002­436­39.­2017.­136­0065.

176. Fairweather, D., Frisancho-Kiss, S., & Rose, N. R. (2008). Sex differences in autoimmune disease from a pathological perspective. American Journal of Pathology, 173(3), 600–609. http://doi.org/­10.­2353/­ajpath.­2008.­071008.

Глава 8

177. Sanders, S. A., Graham, C. A., Bass, J. L., & Bancroft, J. (2001). A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception, 64(1), 51–58. doi:10.1016/­s0010-7824­(01)­00218-9.